The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor
Abstract
Comparisons of the behavioural side-effect profiles of antidepressants that inhibit either serotonin or both serotonin and noradrenaline reuptake, may reveal differences in cognitive and psychomotor functions, which may be attributed to their relative pharmacological selectivity for potentiating monoamine neurotransmission in the central nervous system. The aim of the present study was to determine the acute pharmacodynamic effects of citalopram and venlafaxine, on cognitive and psychomotor performance. Nine healthy male volunteers received a single clinical dose of citalopram, venlafaxine or amitriptyline (positive control) in a double-blind placebo-controlled design. Cognitive and psychomotor tests and a subjective measure of sedation were examined before and 1, 2 and 4 hours after drug administration. Citalopram improved psychomotor responses to sensory stimuli and sustained attention, with significant decreases in movement times of the choice reaction time test and an increase in critical flicker fusion threshold. Venlafaxine did not affect performances on any of the cognitive or psychomotor tests examined. Differences may be related to relative potencies of the compounds for monoamine reuptake inhibition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Aitken, R. C. B. (1969) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576906201005 · Cited by 1,539
The spectrum of behaviors influenced by serotonin
Lucki, I. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00139-5 · Cited by 1,158
Coull, J. T. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00011-2 · Cited by 882
Psychomotor function and psychoactive drugs.
Hindmarch, I. (1980) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1980.tb01745.x · Cited by 524
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492
Scopolamine model of dementia: electroencephalogram findings and cognitive performance
Ebert, & Kirch (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00393.x · Cited by 362
Venlafaxine: A Review of its Pharmacology and Therapeutic Potential in Depression
Holliday, S. M., & Benfield, P. (1995) · Drugs · doi:10.2165/00003495-199549020-00010 · Cited by 327
The effects of antihistamines on cognition and performance
Kay, G. G. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106153 · Cited by 203
Moret, C., Charveron, M., Finberg, J. P. M., Couzinier, J. P., & Briley, M. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90157-1 · Cited by 172
Pharmacokinetics of milnacipran in comparison with other antidepressants
Puozzo, C., & Leonard, B. E. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199609004-00003 · Cited by 99
Research works printed but not linked: 2
- Hasbroucq, 1987, Neurosci Lett, 299, 204
- Hindmarch, 1981, Adv Human Psychopharmacol, 2, 99
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The bright side of being blue: depression as an adaptation for analyzing complex problems.
Andrews, P. W., & Thomson, J. A. (2009) · Psychological Review · doi:10.1037/a0016242 · Cited by 549
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A., & Häussinger, D. (2002) · Hepatology · doi:10.1053/jhep.2002.30957 · Cited by 397
Venlafaxine Extended-Release: A Review of its Use in the Management of Major Depression
Wellington, K., & Perry, C. M. (2001) · CNS Drugs · doi:10.2165/00023210-200115080-00007 · Cited by 263
Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J., & Carnahan, R. (2012) · Drugs & Aging · doi:10.1007/bf03262280 · Cited by 241
Metadata
- Authors
- Nathan, P. J., Sitaram, G., Stough, C., Silberstein, R. B., & Sali, A.
- Affiliations
- Swinburne University of Technology (AU)
- Corresponding author
- Nathan, P.J.
- Venue
- Behavioral Pharmacology
- Published
- 2000-11
- Volume
- 11
- Issue
- 7
- Pages
- 639-642
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W1990883302
- Cited by
- 43
- References
- 23
- Citations by year
- 2024: 1 · 2023: 1 · 2020: 1 · 2019: 1 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- citalopram, venlafaxine, amitriptyline, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, cognitive function, psychomotor performance, sustained attention, choice reaction time, critical flicker fusion threshold, sedation, monoamine reuptake inhibition, antidepressant side effects
- MeSH terms
- Venlafaxine Hydrochloride, Adult, Cognition, Cyclohexanols, Double-Blind Method, Humans, Male, Norepinephrine, Psychological Tests, Psychomotor Performance, Serotonin, Citalopram, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. https://app.cochat.ai/papers/10.1097/00008877-200011000-00011
- The paper
- Nathan, P. J., Sitaram, G., Stough, C., Silberstein, R. B., & Sali, A. (2000). Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behavioral Pharmacology. https://doi.org/10.1097/00008877-200011000-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.